# Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer

> **NCT05384769** · NA · RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 108 (estimated)

## Conditions studied

- Lung Carcinoma

## Interventions

- **PROCEDURE:** Liquid Biopsy
- **PROCEDURE:** Low Dose Computed Tomography of the Chest
- **OTHER:** Survey Administration

## Key facts

- **NCT ID:** NCT05384769
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-07-29
- **Primary completion:** 2029-01-28
- **Final completion:** 2029-01-28
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2025-10-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05384769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05384769, "Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05384769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*